|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Feb 16 | Option Exercise | 65.42 | 3,693 | 241,596 | 56,956 | Feb 21 04:00 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Jan 26 | Sale | 85.00 | 2,419 | 205,615 | 53,263 | Jan 30 04:00 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Oct 01 | Sale | 68.67 | 389 | 26,713 | 31,263 | Oct 04 04:41 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Sep 01 | Sale | 76.71 | 388 | 29,763 | 31,652 | Sep 03 07:40 AM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Aug 02 | Sale | 77.49 | 389 | 30,144 | 32,040 | Aug 04 04:16 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Jun 10 | Option Exercise | 65.42 | 3,845 | 251,540 | 30,390 | Jun 14 04:28 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Jun 10 | Sale | 87.00 | 3,845 | 334,515 | 26,545 | Jun 14 04:28 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Jun 01 | Sale | 84.13 | 395 | 33,231 | 26,545 | Jun 03 04:42 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Apr 01 | Sale | 81.57 | 396 | 32,302 | 27,336 | Apr 05 04:25 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Mar 01 | Sale | 79.73 | 395 | 31,493 | 27,732 | Mar 03 04:28 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Feb 01 | Option Exercise | 65.42 | 961 | 62,869 | 29,483 | Feb 03 04:27 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Feb 01 | Sale | 90.00 | 1,356 | 122,040 | 28,127 | Feb 03 04:27 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Nov 06 | Option Exercise | 65.42 | 961 | 62,869 | 28,971 | Nov 10 04:26 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Nov 06 | Sale | 85.17 | 961 | 81,848 | 28,010 | Nov 10 04:26 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Oct 06 | Option Exercise | 65.42 | 961 | 62,869 | 28,971 | Oct 08 04:21 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Oct 06 | Sale | 91.97 | 961 | 88,383 | 28,010 | Oct 08 04:21 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Sep 08 | Option Exercise | 65.42 | 961 | 62,869 | 28,971 | Sep 10 04:21 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Sep 08 | Sale | 88.94 | 961 | 85,471 | 28,010 | Sep 10 04:21 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Aug 06 | Option Exercise | 65.42 | 961 | 62,869 | 28,971 | Aug 10 04:20 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Aug 06 | Sale | 97.80 | 961 | 93,986 | 28,010 | Aug 10 04:20 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Jul 13 | Option Exercise | 65.42 | 2,419 | 158,251 | 28,010 | Jul 14 04:31 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Jul 06 | Option Exercise | 65.42 | 961 | 62,869 | 26,552 | Jul 07 07:13 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Jul 06 | Sale | 106.58 | 961 | 102,423 | 25,591 | Jul 07 07:13 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Jun 08 | Option Exercise | 65.42 | 961 | 62,869 | 20,948 | Jun 10 04:34 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Jun 08 | Sale | 91.87 | 961 | 88,287 | 19,987 | Jun 10 04:34 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | May 06 | Option Exercise | 65.42 | 961 | 62,869 | 20,948 | May 08 04:53 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | May 06 | Sale | 96.84 | 961 | 93,063 | 19,987 | May 08 04:53 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Apr 06 | Option Exercise | 65.42 | 3,844 | 251,474 | 23,831 | Apr 08 04:35 PM |
INCY | Dhanak Dashyant | EVP & Chief Scientific Officer | Apr 06 | Sale | 85.00 | 3,844 | 326,740 | 19,987 | Apr 08 04:35 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite